INGENIUM PHARMACEUTICALS GMBH has a total of 29 patent applications. Its first patent ever was published in 2004. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are SYNTEX PHARMA LTD, ASHWELL MARK A and ADVENCHEN LAB LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | United States | 3 | |
#4 | Brazil | 2 | |
#5 | Canada | 2 | |
#6 | China | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Mexico | 2 | |
#9 | Australia | 1 | |
#10 | Israel | 1 | |
#11 | New Zealand | 1 | |
#12 | Singapore | 1 | |
#13 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Zeitlmann Lutz | 21 |
#2 | Allgeier Hans | 18 |
#3 | Augustin Martin | 18 |
#4 | Pleiss Michael A | 18 |
#5 | Heiser Ulrich | 16 |
#6 | Mueller Anke | 13 |
#7 | Stumm Gabriele | 9 |
#8 | Wabnitz Philipp | 9 |
#9 | Marquardt Andreas | 9 |
#10 | Schauerte Heike | 8 |
Publication | Filing date | Title |
---|---|---|
CN101889004A | Inhibitors of protein kinases | |
WO2008129070A1 | Inhibitors of protein kinases | |
WO2008129080A1 | 4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases | |
WO2008129069A1 | Inhibitors of protein kinases | |
WO2008129071A1 | Inhibitors of protein kinases | |
EP2137165A1 | Inhibitors of protein kinases | |
WO2008049856A2 | Methods of treating pain using cdk inhibitors |